Hematologic and musculoskeletal disorders segment

KROS

Keros Therapeutics, Inc. - common stock

7.02% up -1.94% 8.96

+ Biopharma, Medicine, Hematologic and musculoskeletal disorders

+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.